ClinicalTrials.govcontrolled
A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)
ClinicalTrials.gov study NCT02212730. IPD Sharing: YES. Countries: 0. Publications: 0.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4